Mounjaro®
Starting from £179.99/mo
Start journey Learn morePayPal Pay in 3 splits a purchase into three interest-free instalments, but whether it can be used for Wegovy depends on how a provider structures its checkout — not on the medicine itself. Wegovy (semaglutide) is a prescription-only medicine, so any legitimate purchase requires a clinical assessment and a valid prescription before payment is even possible. With that context in place, here is what patients looking at instalment options should know about paying for private weight-loss treatment in the UK.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
NICE's appraisal of semaglutide for weight management (NICE TA875) and the STEP 1 trial, published in the New England Journal of Medicine, established that semaglutide 2.4mg produces around 15% average body-weight reduction over 68 weeks, a sustained treatment course, not a short-term one. That duration is relevant to payment because most people will need several pens across many months. At current private market prices, which typically range from roughly £149 to £375 per monthly pen depending on dose and provider (figures that rose significantly after Eli Lilly's September 2025 list-price increase, as widely reported), the total cost of a full course runs to hundreds of pounds for many patients. It is that cumulative figure, not the per-pen sticker, that leads people to search for instalment options like PayPal Pay in 3, and to explore what paying for Wegovy privately actually involves before committing to a course.
A question our prescribers hear most weeks is whether paying in instalments makes treatment safer or riskier. The payment method itself is neutral, what matters is that the underlying supply chain is legitimate and that a qualified prescriber has assessed the patient. Any provider, regardless of how its checkout is structured, must hold a GPhC pharmacy registration; you can check any online pharmacy at the GPhC pharmacy register.
PayPal Pay in 3 divides a transaction into three equal instalments: one at the point of purchase, one a month later, and one the month after that. It is interest-free for the buyer, and PayPal runs its own credit check at the point of application. Crucially, it is a feature that individual merchants enable, not something a buyer can impose on a seller. A pharmacy must have integrated PayPal Pay in 3 into its checkout for it to appear as an option.
For prescription medicines, this creates a practical question: at what point in the ordering process does payment occur? A regulated UK pharmacy must receive a valid prescription before dispensing. Some online pharmacies collect payment at checkout before the prescription is written; others collect it only after clinical approval. This sequencing matters if you are hoping to use an instalment product, because some instalment providers have terms that complicate or exclude regulated pharmaceutical transactions. Whether a specific pharmacy enables Pay in 3 for Wegovy orders is something to confirm directly with that provider, it is not a feature that can be assumed.
If you are exploring the broader question of paying for Wegovy in instalments, the key check is whether the option your provider offers is integrated at the right point in the clinical process.
When comparing payment options, the more useful question is what a given price covers. Private Wegovy treatment at a regulated provider should include the clinical consultation, the prescription fee, the medicine itself, delivery, and ongoing clinical support. Providers that strip these out and charge separately can make a headline price look lower than it is.
At nume, one transparent price covers the free consultation, the prescription, the treatment, and free next-working-day tracked delivery, with priority aftercare available seven days a week. There are no subscriptions and no auto-renewals; every repeat order is clinically reviewed again before it is dispatched. We do not offer discount codes or promotional pricing for prescription medicines. Current treatment pricing is shown on the Wegovy price page, and a fuller comparison of what private payment routes look like is available on our self-pay guide.
For patients weighing up instalment products like Pay in 3 or Clearpay, it is worth reading our Wegovy Clearpay page, which covers similar ground on buy-now-pay-later options. The monthly payment options page also sets out how structured payment plans differ from third-party instalment products.
The NHS medicines page for semaglutide is clear that this is a prescription-only treatment requiring medical assessment. That assessment exists because Wegovy is not suitable for everyone: it is not licensed for use during pregnancy, breastfeeding, or when trying to conceive, and it is not prescribed to under-18s. Certain medical histories (including a personal or family history of medullary thyroid carcinoma or a condition called MEN2) require careful prescriber review. Semaglutide also has a GI-led side-effect profile (nausea, vomiting and diarrhoea are the most frequently reported) that a prescriber factors into the clinical picture before and during treatment.
None of this is changed by how a patient pays. A seller offering Wegovy without requiring a prescription (regardless of the payment method on offer) is not operating legally. The MHRA has seized large volumes of fake weight-loss pens sold through unregulated channels; the payment flexibility they advertise is not a selling point, it is a warning sign. Reporting suspect sellers is possible through the MHRA Yellow Card scheme.
If you are ready to explore whether Wegovy is clinically appropriate for you, a consultation with our prescribers is the right starting point. Speak to our prescribers and receive a same-day clinical review from a GPhC-registered Independent Prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.